COVID-19: 'Real-world' analysis of coronavirus vaccine in Israel raises questions about UK strategy
The first real-world analysis of the Pfizer/BioNTech coronavirus vaccine suggests it is matching its performance in clinical trials, but raises serious questions about the UK's decision to delay the second dose. Scientists in Israel - which is leading the COVID-19 vaccination race - have told Sky News that they are 'very hopeful' having studied preliminary data from 200,000 vaccinated people. But crucially they say their results do not show efficacy at a level close to that used by the UK to justify delaying the second dose of the Pfizer/BioNtech jab.
Sky News - January 20, 2021View the full story here: https://news.sky.com/story/covid-19-real-world-analysis-of-vaccine-in-israel-raises-questions-about-uk-strategy-12192751